Europe's targets for clinical trials by 2030 are reportedly not being met. The issue appears to be related to the pharmaceutical industry and healthcare in europe, with some reports mentioning specific diseases such as hiv and cancer. However, the exact nature and scope of the problem are unclear, with various outlets discussing different aspects of european healthcare and industry.